Lionberger R - Search Results

1

Use of partial area under the curve metrics to assess bioequivalence of methylphenidate multiphasic modified release formulations.

Stier EM, Davit BM, Chandaroy P, Chen ML, Fourie-Zirkelbach J, Jackson A, Kim S, Lionberger R, Mehta M, Uppoor RS, Wang Y, Yu L, Conner DP. Stier EM, et al. Among authors: lionberger r. AAPS J. 2012 Dec;14(4):925-6. doi: 10.1208/s12248-012-9397-7. Epub 2012 Sep 14. AAPS J. 2012. PMID: 22976173 Free PMC article. No abstract available.

2

Applications of process analytical technology to crystallization processes.

Yu LX, Lionberger RA, Raw AS, D'Costa R, Wu H, Hussain AS. Yu LX, et al. Among authors: lionberger ra. Adv Drug Deliv Rev. 2004 Feb 23;56(3):349-69. doi: 10.1016/j.addr.2003.10.012. Adv Drug Deliv Rev. 2004. PMID: 14962586 Review.

3

Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral bioavailability of P-glycoprotein substrates.

Kwon H, Lionberger RA, Yu LX. Kwon H, et al. Mol Pharm. 2004 Nov-Dec;1(6):455-65. doi: 10.1021/mp049921x. Mol Pharm. 2004. PMID: 16028357

4

Bioequivalence approaches for highly variable drugs and drug products.

Haidar SH, Davit B, Chen ML, Conner D, Lee L, Li QH, Lionberger R, Makhlouf F, Patel D, Schuirmann DJ, Yu LX. Haidar SH, et al. Among authors: lionberger r. Pharm Res. 2008 Jan;25(1):237-41. doi: 10.1007/s11095-007-9434-x. Epub 2007 Sep 22. Pharm Res. 2008. PMID: 17891552 Review.

5

Spreadability measurements to assess structural equivalence (Q3) of topical formulations--a technical note.

Kryscio DR, Sathe PM, Lionberger R, Yu L, Bell MA, Jay M, Hilt JZ. Kryscio DR, et al. Among authors: lionberger r. AAPS PharmSciTech. 2008;9(1):84-6. doi: 10.1208/s12249-007-9009-5. Epub 2008 Jan 12. AAPS PharmSciTech. 2008. PMID: 18446465 Free PMC article. No abstract available.

6

FDA critical path initiatives: opportunities for generic drug development.

Lionberger RA. Lionberger RA. AAPS J. 2008;10(1):103-9. doi: 10.1208/s12248-008-9010-2. Epub 2008 Feb 20. AAPS J. 2008. PMID: 18446510 Free PMC article. Review.

7

Quality by design: concepts for ANDAs.

Lionberger RA, Lee SL, Lee L, Raw A, Yu LX. Lionberger RA, et al. AAPS J. 2008 Jun;10(2):268-76. doi: 10.1208/s12248-008-9026-7. Epub 2008 May 9. AAPS J. 2008. PMID: 18465252 Free PMC article.

8

Generic omeprazole delayed-release capsules: in vitro performance evaluations.

Moore T, Smith A, Ye W, Toler DY, Westenberger BJ, Lionberger R, Raw A, Yu L, Buhse LF. Moore T, et al. Among authors: lionberger r. Drug Dev Ind Pharm. 2009 Aug;35(8):917-21. doi: 10.1080/03639040802698802. Drug Dev Ind Pharm. 2009. PMID: 19555236

9

Analysis of bead sizes for MR capsules labeled for sprinkle.

Nagavelli LR, Lionberger RA, Sayeed VA, Yu L, Allgire J, Smith A, Wokovich A, Westenberger BJ, Buhse L. Nagavelli LR, et al. Among authors: lionberger ra. AAPS PharmSciTech. 2010 Dec;11(4):1508-10. doi: 10.1208/s12249-010-9529-2. Epub 2010 Oct 9. AAPS PharmSciTech. 2010. PMID: 20936439 Free PMC article.

10

Utility of physiologically based absorption modeling in implementing Quality by Design in drug development.

Zhang X, Lionberger RA, Davit BM, Yu LX. Zhang X, et al. AAPS J. 2011 Mar;13(1):59-71. doi: 10.1208/s12248-010-9250-9. Epub 2011 Jan 5. AAPS J. 2011. PMID: 21207216 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters